• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Transaction Data Systems Announces Acquisition of Pharm Assess, Inc.

Share:

April 8, 2019

Pharm Assess and its Retail Business Solutions join the broad array of products and services TDS offers independent and community pharmacies

Transaction Data Systems, parent company of the Rx30 and Computer-Rx pharmacy management systems, today publicly announced the acquisition of Pharm Assess, Inc. and its Retail Business Solutions product suite. Pharm Assess RBS offers comprehensive business solutions that drive profitability at the pharmacies by supporting compliance with pharmacy and staff credentialing and providing audit assistance, third party payer contract assistance, financial reporting, 340B program assistance and much more.

The Pharm Assess Retail Business Solutions will be integrated with the other TDS technologies and will provide comprehensive business solutions to independent and community pharmacies. RBS technologies and programs will be available any community pharmacy-TDS platform users, as well as community pharmacies utilizing non-TDS pharmacy management systems.

TDS’ Rx30 and Computer-Rx customers will have access to all programs and services offered through the RBS menu. The technology and services can be bundled, with several options available a la carte. Product and service options include:

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Financial and Analytical Reporting
Cash Pricing Assistance
Inventory Management Tools
340B Profitability and Analysis
Third Party Payer Contracting Assistance
Third Party Payer Audit Assistance
Vaccination Programs
Pharma Co-pay and Trial Card Pay Assistance Program
Controlled Substance Patient Monitoring Program

“Our pharmacist-owned and operated comprehensive retail business solution (RBS) offering incorporates over 20 years of experience working closely with pharmacy owners,” stated Monty Rogers, R.Ph., President and owner of Pharm Assess, Inc. “Independent and community pharmacies need their key vendors to be experienced and readily available business partners in this fast-pace and ever-changing industry. With this acquisition, I’m glad we will be able to deeply integrate our program with the TDS platforms to bring enormous scale in making affordable real-time business solutions available to independent and community pharmacy businesses.”

“TDS is excited to announce this acquisition. Pharm Assess and Monty Rogers will bring valuable insight gained from 20 years of experience in our industry, where Monty has worked side-by-side with independent and community pharmacies for decades,” said Jude Dieterman, TDS CEO. “Monty’s experience with business solutions, managed care and third-party payer contracts will bring substantial knowledge to the TDS strategic roadmap as we continue to bring technology and innovation to our clients.”

Date: April 08, 2019

Source: WFMJ

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Amazon Releases New Alexa Features Allowing Families to Monitor Seniors Living AloneAmazon Releases New Alexa Features Allowing Families to Monitor Seniors Living Alone
  • Employer-Focused Behavioral Health Startup Lyra Scores $200MEmployer-Focused Behavioral Health Startup Lyra Scores $200M
  • Hippocratic AI Raises $15M and More Digital Health FundingsHippocratic AI Raises $15M and More Digital Health Fundings
  • Quartet Health, Cambia Health Solutions Partner to Bring AI-enabled Platform to Cambia’s MembersQuartet Health, Cambia Health Solutions Partner to Bring AI-enabled Platform to Cambia’s Members
  • TRACON Pharmaceuticals Announces up to $30m Non-recourse Non-Dilutive Financing Related to Arbitration Award Decision Expected in Q1 2023TRACON Pharmaceuticals Announces up to $30m Non-recourse Non-Dilutive Financing Related to Arbitration Award Decision Expected in Q1 2023
  • The Academy and Nuance Partner to Launch the AI CollaborativeThe Academy and Nuance Partner to Launch the AI Collaborative
  • Tusk Therapeutics to be acquired by RocheTusk Therapeutics to be acquired by Roche
  • Carbios Enters Joint Development Agreement With Novozymes to Produce Its Proprietary Enzyme for Complete Recycling of PET-plastics and FibersCarbios Enters Joint Development Agreement With Novozymes to Produce Its Proprietary Enzyme for Complete Recycling of PET-plastics and Fibers

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications